Article: ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test.

Abaxis, Inc. (NASDAQ: ABAX), a medical products company manufacturing point-of-care blood analysis instruments for the medical, research and veterinary markets, announced that it has received USDA approval for its Canine Heartworm Antigen Test to be performed on the company's VetScan VS2 fully automated instrument. The Heartworm assay is now performed in the instrument alongside and simultaneously with eleven other important Canine health determinations, providing reliable results in minutes, at the point-of-care, and from only two drops of whole blood (see also Abaxis, Inc.).

Ken Aron, Chief Technology Officer for Abaxis commented, "In the course of our ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!